Kerckhoff Klinik
Bad Nauheim, 61231, Germany
NCT Number: NCT03023475
Endoscopic radial artery harvesting in coronary bypass surgery is routinely performed by the investigators. In this study, the investigators want to compare the MiFusion TLS2 (Endotrust GmbH, Germany) device to the LigaSure Maryland Jaw (Medtronic, USA). The vessel harvesting is performed in the standard fashion according to the institutional routine. The patients are randomized preoperatively to one of the devices. The proximal end of the radial artery will be preserved and deep-frozen for histological assessment. Endothelial integrity will be investigated using Hematoxylin-Eosin, CD31 and endothelial nitrogen monoxide synthase.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bad Nauheim, 61231, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The radial artery will be harvested endoscopically using the LigaSure system.
The radial artery will be harvested endoscopically using the TLS2 system.
Time frame: Through study completion, an average of 1 year.
Time frame: The harvesting time will be measured during the vessel harvesting surgery.
Time frame: Intraoperatively and directly after vessel harvesting the arm is controlled using the endoscope and bleeding can be detected during this control. End of surgery is end of this outcome parameter.
Time frame: The blood insufflation is performed immediately after vessel harvesting and leaks can be detected.
Kerckhoff Klinik
Other
Prospective Randomized Comparison of Two Different Endoscopic Radial Artery Harvesting Devices
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07663435
Agnosia, CABG Graft Integrity
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07485738
Blood Flow, CABG
New York, United States
View Trial Details